Clinical Trial Update: A Randomized Controlled Study Comparing the Safety and Efficacy of Irinotecan Hydrochloride Liposome Injection Combined With Temozolomide and Vincristine (NALIRI-VT) Versus Irinotecan Combined With Temozolomide and Vincristine (VIT) in Patients With Advanced Ewing's Sarcoma [Phase 2]

View source ↗

Summary

A Phase 2 randomized trial comparing liposomal irinotecan-based combination therapy (NALIRI-VT) with standard irinotecan-based therapy (VIT), both given with te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• Irinotecan hydrochloride injection (Irinotecan hydrochloride)
• Irinotecan hydrochloride liposome injection (irinotecan liposome injection)
• Temozolomide (Temozolomide)
• Vincristine (vincristine)

Snippet

Sponsor: Tang Xiaodong | Conditions: Ewing's Sarcoma | Phase 2 | Status: NOT_YET_RECRUITING